Role of FAP-positive cells in immune response to irradiated glioblastoma
FAP 阳性细胞在放射胶质母细胞瘤免疫反应中的作用
基本信息
- 批准号:10649237
- 负责人:
- 金额:$ 23.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-10 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:Abscopal effectAdultAlpha CellBrainBrain NeoplasmsBreast Cancer ModelCD8-Positive T-LymphocytesCD8B1 geneCarcinomaCellsColorectal CancerDataDiseaseEffector CellExclusionExhibitsFDA approvedFibroblastsFlow CytometryGene Expression ProfileGlioblastomaHumanITGAX geneImmuneImmune EvasionImmune responseImmune systemImmunityImmunologic StimulationImmunosuppressionImpairmentIn VitroInfiltrationKnowledgeLymphocytic InfiltrateMalignant NeoplasmsMalignant neoplasm of ovaryMediatingMembraneMicrogliaMicrosatellite RepeatsModalityModelingMorphologyMusMyeloid CellsNeoplasmsPatientsPeptide HydrolasesPhenotypePropertyProteinsRadiation therapyRecurrenceRecurrent tumorReportingResearchResistanceRoleSerineSerine ProteaseSignal TransductionSolid NeoplasmSortingStimulusStromal CellsSurfaceT-LymphocyteTestingTransforming Growth Factor betaTreatment EfficacyTumor EscapeTumor ImmunityUrotheliumVEGFA geneWorkanti-PD-1cancer therapycell typecytotoxiceffective therapyfibroblast activation protein alphaimmune cell infiltrateimmune resistanceimmunogenicimmunogenicityimprovedin vivoinnovationirradiationmalignant breast neoplasmmembermouse modelnovelnovel strategiesnovel therapeutic interventionpharmacologicpre-clinicalpreventprogrammed cell death ligand 1programmed cell death protein 1recruitresistance mechanismsingle-cell RNA sequencingstandard of caresynergismtemozolomidetumortumor microenvironmenttumor-immune system interactions
项目摘要
PROJECT SUMMARY
Glioblastoma (GBM) is a devastating brain tumor disease with a median overall survival of approximately 15
months. GBM patients die because of the constant ability of GBM to acquire resistance mechanisms against
anti-cancer therapies, therefore leading to an inevitable tumor recurrence.
A. Radiation therapy (RT) is a pivotal modality for improving overall survival of GBM. However, GBM invar-
iably recurs, which suggests that RT is eliciting or exacerbating mechanisms of resistance in GBM. Identifying
and overcoming the contributing factors involved in GBM resistance is a major challenge. Immunosup-
pression exerted by cells expressing fibroblast activating protein-alpha (FAP) can account for the lack of immu-
nogenicity of irradiated GBM. FAP is a type II transmembrane serine protease that is heavily expressed in the
stroma of multiple solid tumors and has thus become a marker to identify cancer-cell associated fibroblasts
(CAFs). While our knowledge about CAFs or CAF-like cells in GBM is limited. Few studies reported the presence
of glioblastoma-associated stromal cells (GASCs) that share phenotypic and functional properties of CAFs de-
scribed in the stroma of carcinomas, but none investigated the role of this cell type in respect to immunosup-
pression of irradiated GBM. Our preliminary analyses suggest that FAP+ cells represent a major immune sup-
pressive subset in irradiated GBM. Specifically, we demonstrate that (1) FAP+ cells with fibroblastic morphology
surround GBM tumor, (2) FAP is mostly expressed by tumor infiltrating myeloid cells in vivo, (3) in vitro irradiation
of GBM and microglia cells enhances FAP together with PD-L1 and PD-L2 expressions and (4) targeting FAP
increases the recruitment of CD8+ T cells and CD11c+ into GBM in vivo. This work shed light on FAP+ cells as
a master regulator of anti- immunity and identifies FAP targeting as a new strategy to immune reactivity of irra-
diated GBM. In this application, we propose to test the novel and innovative hypothesis that FAP+ cells
represent a major immune suppressive subset that provide the means to suppress anti-tumor immunity in
GBM. Successful completion of this work will (1) uncover the role of FAP+ cells in immunosuppression
of irradiated GBM and (2) provide evidence for a novel therapeutic intervention that will break through
immune resistance of irradiated GBM by targeting FAP.
项目摘要
胶质母细胞瘤(GBM)是一种毁灭性的脑肿瘤疾病,中位总生存期约为15
个月GBM患者死亡是因为GBM获得抵抗机制的恒定能力,
抗癌治疗,因此导致不可避免的肿瘤复发。
A.放射治疗(RT)是提高GBM总生存率的关键方法。然而,GBM因瓦-
这表明RT引发或加剧了GBM中的耐药机制。识别
并且克服涉及GBM抗性的促成因素是一个主要挑战。免疫抑制剂
由表达成纤维细胞活化蛋白-α(FAP)的细胞施加的表达可以解释免疫缺陷的缺乏。
照射GBM的致瘤性。FAP是一种II型跨膜丝氨酸蛋白酶,其大量表达于细胞膜中。
基质的多种实体瘤,并因此成为一种标志物,以确定癌细胞相关的成纤维细胞
(CAFs)。但我们对GBM中CAF或CAF样细胞的认识有限。很少有研究报道
胶质母细胞瘤相关的基质细胞(GASC),共享CAFs的表型和功能特性,
在癌的间质中转录,但没有人研究这种细胞类型在免疫抑制方面的作用。
照射GBM的压力。我们的初步分析表明,FAP+细胞是一种主要的免疫抑制剂,
受照射的GBM中的抑制亚群。具体而言,我们证明:(1)FAP+细胞具有成纤维细胞形态,
FAP主要表达于肿瘤周围的骨髓细胞,(2)体内FAP主要表达于肿瘤浸润的骨髓细胞,(3)体外照射
GBM和小胶质细胞的表达增强FAP以及PD-L1和PD-L2的表达,以及(4)靶向FAP
增加体内CD 8 + T细胞和CD 11 c+向GBM的募集。这项工作揭示了FAP+细胞,
抗免疫的主要调节剂,并确定FAP靶向作为一种新的策略,免疫反应性的irra,
扩张性GBM。在本申请中,我们提出测试FAP+细胞
代表一个主要的免疫抑制亚群,其提供了抑制抗肿瘤免疫的手段,
GBM。这项工作的成功完成将(1)揭示FAP+细胞在免疫抑制中的作用
和(2)为一种新的治疗干预提供证据,
通过靶向FAP的辐射GBM的免疫抗性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Claire Isabelle Vanpouille-Box其他文献
Claire Isabelle Vanpouille-Box的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Claire Isabelle Vanpouille-Box', 18)}}的其他基金
Fatty Acid Metabolic Regulation of Anti-Tumor Immunity Against Irradiated Glioblastoma
脂肪酸代谢调节抗辐射胶质母细胞瘤的免疫
- 批准号:
10638744 - 财政年份:2023
- 资助金额:
$ 23.77万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 23.77万 - 项目类别:
Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 23.77万 - 项目类别:
Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 23.77万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 23.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 23.77万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 23.77万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 23.77万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 23.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 23.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 23.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)